A Recent Research on Mesothelioma

In a current issue of the Journal of Clinical Oncology, a report was found regarding mesothelioma which is as follows. A recent study on mesothelioma by some researchers showed that the condition of a mesothelioma patient suffering from the rare malignant pleural mesothelioma can be much improved by giving him a combination of Tomudex (raltitrexed) and Platinol (cisplatin). By using this combination, the survival rate of the patient is also improved rather than by using Platinol alone. This rare malignant pleural mesothelioma is caused by habitual exposure to asbestos.
The above research findings about mesothelioma were emerged from a randomized phase III trial.

The symptoms of the patient suffering from this rare mesothelioma are listed below:

* Cough
* Pain
* Fatigue
* Loss of appetite
* Shortness of breath,

This rare type of mesothelioma cancer is very difficult to cure. Also, it does not respond to therapies like surgery, chemotherapy on its' own and even when a combination of radiation is used. In such cases, any kind of new researches related to cure the disease becomes more encouraging.

Usually the complication is that the patients do not recognize that they are suffering from malignant pleural mesothelioma and when the disease is diagnosed, it has been increased to such an extent where using the treatments like surgery or radiation is not a suitable option.

So it is significant to do more researches in this field and to identify treatments that will improve the condition of mesothelioma patient and also, improve their survival.